Literature DB >> 11850811

Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression).

Pankaj Seth1, Ian Krop, Dale Porter, Kornelia Polyak.   

Abstract

The breast cancer promoting effects of estrogen and the chemopreventive effects of tamoxifen are thought to be mediated by the estrogen receptor, a ligand-dependent transcription factor. Therefore, comprehensive analysis of gene expression profiles following estrogen or tamoxifen treatment may help us better understand the role estrogen plays in tumorigenesis. We utilized SAGE (Serial Analysis of Gene Expression) technology to identify genes regulated by estrogen and tamoxifen in the ZR75-1 estrogen dependent breast cancer cell line. In this manner we have identified several genes that were regulated by estrogen or tamoxifen. Here we report the identification and initial characterization of EIT-6 (Estrogen Induced Tag-6), a novel nuclear protein and a new member of the evolutionarily conserved SM-20 family of growth regulatory immediate-early genes. EIT-6 appears to be a direct transcriptional target of the estrogen receptor and constitutive expression of EIT-6 promotes colony growth in human breast cancer cells. These data indicate that EIT-6 may play a role in estrogen induced cell growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850811     DOI: 10.1038/sj.onc.1205113

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

Review 1.  The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling.

Authors:  Edurne Berra; Amandine Ginouvès; Jacques Pouysségur
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

Review 2.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

3.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.

Authors:  Josée Laganière; Geneviève Deblois; Céline Lefebvre; Alain R Bataille; François Robert; Vincent Giguère
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

4.  HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression.

Authors:  Daniel A Tennant; Eyal Gottlieb
Journal:  J Mol Med (Berl)       Date:  2010-04-11       Impact factor: 4.599

5.  The PHD1 oxygen sensor in health and disease.

Authors:  Kilian B Kennel; Julius Burmeister; Martin Schneider; Cormac T Taylor
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

Review 6.  Hypoxia inducible factor-1: its potential role in cerebral ischemia.

Authors:  Neetu Singh; Gaurav Sharma; Vikas Mishra
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

Review 7.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

8.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.

Authors:  Jan H Marxsen; Petra Stengel; Kathrin Doege; Pekka Heikkinen; Terhi Jokilehto; Thomas Wagner; Wolfgang Jelkmann; Panu Jaakkola; Eric Metzen
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

9.  Clustering of molecular alterations in gastroesophageal carcinomas.

Authors:  Natalie Koon; Alexander Zaika; Christopher A Moskaluk; Henry F Frierson; Sakari Knuutila; Steven M Powell; Wa'el El-Rifai
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

Review 10.  Identifying estrogen receptor target genes.

Authors:  Willem-Jan Welboren; Henk G Stunnenberg; Fred C G J Sweep; Paul N Span
Journal:  Mol Oncol       Date:  2007-05-08       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.